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Abstract
Bacgraund/Aim. The use of new therapeutic methods to
prevent development of fibrothorax as the final complica-
tion of the human pleural infections requires research with
experimental animals. The aim of this study was to stan-
dardize the procedures for the establishment of our own
experimental model of empyema in rabbits, since it should
be able to offer similar conditions found in human pleural
infections. Methods. This experiment included 15 chin-
chilla rabbits, weighing from 2.3 to 2.8 kg. There were 12
rabbits in the experimental group, while 3 rabbits formed
the control group. On the first day, we administered 0.4–
0.5 mL of turpentine in the right pleural space of the
rabbits from the experimental group in order to provoke
sterile exudative pleurisy. After 24 h we injected 1 mL of
Staphylococcus aureus and 1 mL of Escherichia coli bacteria in
the same concentration of 4.5 u 108  bacteria/mL.
Thoracocentesis for the pleural fluid analysis was
performed 24, 48, 72, and 96 h after bacteria instillation.
In these pleural samples we estimated the number of
leucocytes and the values of lactate dehydrogenase (LDH),
glucose and pH in pleural fluid, as well as the presence of
bacteria. We did not protect the animals with antibiotics,
and on the day 7 of the experiment they were sacrificed
with the lethal dose of barbiturate (iv). The lung from the
empyemic side of all experimental animals and the lung of
one control animal were histopathologically examined.
Results. A total of 4 animals had a small amount of clear
pleural fluids or there was no fluid obtained with
thoracocentesis 24 and 48 h after the bacteria instillation.
after the bacteria instillation. In the remaining 8 rabbits 24
h after bacteria administration the mean values (± SD) of
the parameters monitored were as follows: Le
34.75 ± 6.13 u 109/L, LDH 17,000 ± 4,69 U/L, glucose
1.23 ± 0.45 mmol/L, and pH 6.975 ± 0.15. The obtained
values met the criteria for the evaluation of effusion as
pleural empyema or complex and complicated pleural ef-
fusion (LDH > 1000 U/L, glucose < 2.31 mmol/L and
pH < 7.20). Bacterial cultures were positive in 5 out of 8
first pleural samples and in only 2 samples after 48 h of
bacteria administration. There was a positive correlation
between the number of leukocytes and the LDH value (r
= 0.071, p  <  0.001), and a negative correlation between
the number of leukocytes and the glucose level (r = 0.864,
p  <  0.001), and the leukocytes number and pH of the
pleural fluid (r = 0.894, p  <  0.001). The mean glucose
value increased after 48 h (3.23 ± 0.44 mmol/L), and the
pH value rose after 72 h (7.22 ± 0.03) which was beyond
the empyema level. Conclusion. The creation of the ex-
perimental empyema model is a very delicate work with
uncertain success. Its value and importance are crucial for
pleural pathology research. With the intention to obtain a
more empyemic pleural reaction we created a model with
two different human pathogen bacteria. We generated the
satisfactory results, but not as good as those contained in
some of the reference literature data.
Key words:
empyema, pleural; animal experimentation; rabbits;
pleural effusion; bacteria.
Apstrakt
Uvod/Cilj. Primena novih metoda leÿenja u cilju spreÿavanja
razvoja fibrotoraksa, kao krajnje komplikacije empijema zah-
teva prethodno ispitivanje na eksperimentalnim životinjama.
Cilj rada bio je standardizovanje postupaka za ustanovljavanje
pouzdanog eksperimentalnog modela empijema kod kuniýa.
Metode. U eksperimentu je korišýeno 15 ÿinÿila kuniýa mase
od 2 300 do 2 800 g. Eksperimentalnu grupu ÿinilo je 12 ku-
niýa, a kontrolnu tri. Prvog dana eksperimenta, u desni pleu-
ralni prostor kuniýa iz eksperimentalne grupe stavljeno je 0,4–
0,5 mL terpentina u cilju izazivanja sterilnog eksudativnog
pleuritisa. Nakon 24 sata u pleuralni prostor stavljen je 1 mL
Staphylococcus aureus-a i 1 mL Escherichia coli bakterija iste kon-
centracije (4,5 u 108 bakterija/mL). Torakocenteza je raĀena
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uzoraka pleuralne teÿnosti. U ovim uzorcima odreĀivane su
vrednosti leukocita (Le), laktat dehidrogenaze (LDH), gluko-
ze, pH u pluralnoj teÿnosti i prisustvo bakterija. U toku ek-
sperimenta životinje nisu dobijale antibiotik, a žrtvovane su
sedam dana od primene bakterija letalnom dozom barbiturata
iv. Patohistološki su pregledana sva pluýa sa empijemom svih
eksperimentalnih životinja, kao i pluýa jedne kontrolne živo-
tinje. Rezultati. Kod ÿetiri životinje dobijen je oskudan bistar
sadržaj, ili sadržaja nije bilo prilikom punkcija 24 i 48 ÿasova
od primene bakterija. Kod preostalih 8 eksperimentalnih ži-
votinja srednja vrednost Le u izlivu 24 ÿasa nakon primene
bakterija bila je: 34,75 ± 6,13 u 109/L, LDH 17,000 ± 4,69
U/L, glukoze 1,23 ± 0,45 mmol/L, a pH 6,975 ± 0,15. Na-
vedene vrednosti ispunjavaju kriterijume za proglašavanje iz-
liva empijemskim ili kompleksnim, komplikovanim izlivom
(LDH > 1 000 U/L, glukoza < 2,31 mmol/L i pH < 7,20).
Bakteriološke kulture bile su pozitivne kod pet od osam prvih
uzoraka, a nakon 48 ÿasova samo kod dva uzorka pleuralnog
izliva. UtvrĀeno je postojanje pozitivne korelacije izmeĀu
broja leukocita i vrednosti LDH (r = 0,071, p < 0.001), a ne-
gativne korelacije izmeĀu broja leukocita i vrednosti glukoze
(r = 0,864, p < 0.001) i broja leukocita i vrednosti pH izliva
(r = 0,894, p  < 0.001). Vrednost glukoze nakon 48 sati
(3,23 ± 0,44 mmol/L) i pH nakon 72 sata (7,22 ± 0,03),
izašle su iz okvira empijemskih vrednsoti. Zakljuÿak.
Kreiranje eksperimentalnog modela empijema veoma je
delikatan posao, sa neizvesnim uspehom. Dobar eksperi-
mentalni model od suštinskog je znaÿaja za prouÿavanje
pleuralne patologije. U cilju što boljeg pleuralnog odgovo-
ra napravili smo model sa dve humane patogene bakterije.
Dobili smo zadovoljavajuýe rezultate, mada slabije od onih
koji su objavljeni u literaturi.
Kljuÿne reÿi:
empijem; životinje, zaštita; zeÿevi; pleura, izliv;
bakterija.
Introduction
Pleural empyema is a serious inflammatory disease
which is characterized by the presence of purulent effusion
in the pleural space and, almost always arises as a complica-
tion of some other disease or condition. The clinic phases of
empyema are acute, intermediate and chronic and these are
counterparts of exudative, fibropurulent and fibrous patho-
logic stage of the disease 
1, 2.
Despite effective antibiotic therapy and different drain-
age options which are available today for drainage of pleural
infectious space, pleural empyema remains a serious medical
problem with morbidity and mortality up to 20%. Half of all
empyemas are consequences of inappropriate pneumonia
treatment. Other causes may be a thoracic trauma, surgical
procedures and infection spreading from the surrounding or-
gans 
3–5.
Pleural effusion is found in 9–30% of cases of bacterial
pneumonia. The frequency is much higher among hospital-
ized patients (33–66%). Patients with unilateral and bilateral
parapneumonic effusion have 3.7 and 6.5 times higher mor-
tality rate, respectively 
6, 7.
Thoracic drainage along with antibiotics is the most
frequent initial empyema treatment. The choice of treatment
modality depends on the severity of the disease and the stage
of illness at the moment of diagnosis, as well as on patient’s
overall condition.
In addition to the thoracic drainage there are other
treatment modalities, such as: drainage with intrapleural ap-
plication of fibrinolytics, video-assisted thoracoscopic sur-
gery (VATS) debridement, thoracotomy with decortication,
open drainage and thoracoplasty 
8–10. The main goal of em-
pyema treatment is cleaning of purulent pleural content, fol-
lowed by lung reexpansion intending to avoid complications
and the need for second operation 
1, 2, 11.
Despite the fact that up to 20% of pleural parapneu-
monic effusions progress to empyema and that up to 40% of
empyemas need a more aggressive surgical treatment, most
of thoracic surgery centers usually have a few empyema pa-
tients. That is why there are very few randomized prospec-
tive trials with the purpose to compare efficacy of empyema
treatment modalities 
12.
The first experimental empyema model was made by
Graham and Bell and they performed it on dogs almost a cen-
tury ago. The rabbit turpentine model, the pig model with um-
bilical cord and the rabbit model with nutritive agar were made
in the last 30 years of the last century. These models were used
for the basic empyema research at the beginning of the last
century 
13, for studying therapeutic and drainage procedures ef-
ficacy 
3, 14  and antibiotics used in the empyema treatment 
9, 15.
Richard W. Light established well-known criteria for
parapneumonic effusions and empyemas classification. A
parapneumic effusion will be classified as an empyema if its
glucose level is lower than 40 mg/dL or 3.0 mmol/L, pH
value under 7.0 and lactate delydrogenase (LDH) value
above 1000 I/U. Beside these biochemical parameters, posi-
tive bacteriological cultures or frank pus in pleural space
have the same importance 
16.
In the last few years the experimental empyema model
has been used for basic research again, but this time on the
cellular level, studying the role of some pro-inflammatory
and pro-fibrotic cytokines and possibilities of the therapeutic
use of their antagonist or inhibitors.
Most promising is the use of transforming growth fac-
tor-ȕ (TGF-ȕ) antagonists to prevent proliferation of fibro-
blasts and deposition of extracellular matrix which are re-
sponsible for fibrothorax formation 
16.
It is obvious that therapeutic potentials of the above-
mentioned surgical procedures leave room for the research of
new substances, which could be applied in empyema treat-
ment. Our goal was to make a reliable experimental empy-
ema model that would enable us to participate and continue
these studies.
Methods
Experimental animals
The research was approved by the Military Medical
Academy Ethics Committee. We used 15 four-month-old
male chinchilla rabbits, weighing 2.3-2.8 kg. The rabbitsVolumen 71, Broj 5 VOJNOSANITETSKI PREGLED Strana 493
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were from the Institute for Medical Research farm of the
Military Medical Academy. They were placed in separate
boxes. They were given food and water ad libitum. We ran-
domised two groups: the experimental one with 12 rabbits
with intrapleural application of bacteria, and the control one
with 3 rabbits without application of bacteria.
Bacteria preparation
In this experiment we used Staphyloccocus aureus
ATCC 25923 strain, and Esherichia coli ATCC 25922 strain.
Concentration of the bacteria was determined under McFar-
land scale (Biomerieux, Densi chek plus McF). We adminis-
tered 1 mL saline solution with 4.5 u 10
8/mL (1.5 McF)
Staphyloccocus aureus and 1 mL saline solution with Esher-
ichia coli bacteria in the same concentration. The day before
the application bacteria were seeded on fresh blood agar.
Empyema induction
The rabbits from the experimental group were anesthe-
tized with ketamine, 35 mg/kg, (Laboratorio Sanderson,
Santiago Chile), and acepromazine 0.1 mg/kg (Ceva Tierge-
sundheit GmbH Dusseldorf, Germany). The right chest wall
from the sternal to scapular line of each rabbit was shaved
and scrubbed with povidon iodine (Betadine
®).
The animals were placed in the supine position on the
operating table. With the surgical knife, we made a small, 5
mm long incision, between the middle and lower third of the
right hemithorax, 2.5–3 cm from the sternal edge. We per-
formed thoracocentesis with a Mediflon iv catheter 18 G u 1.3
u 45 mm, flow 90 mL/min (Eastern Medikit Ltd. Gurgaon In-
dia). After we had excluded the presence of pneumothorax
with probe aspiration, we injected 0.5–0.6 mL of turpentine
through the catheter in the right pleural space of each experi-
mental rabbit. After turpentine application the catheter was
rinsed with 0.5 mL of saline solution. The aim of turpentine
application was to cause a chemical pleural lesion followed by
sterile effusion. Skin suture was not necessary. We did not in-
ject turpentine and bacteria into the rabbits from the control
group and did not perform any thoracocentesis.
After 24 h we conducted the same anesthesia proce-
dures and thoracocentesis and then 8 experimental rabbits
were administered 2 mL of saline solution with the above-
mentioned bacteria concentration. The catheter was rinsed
with 0.5 mL of saline solution. The animals were gently ro-
tated manually in order to spread the bacterial solution uni-
formly in the pleural space.
Experimental animals were given 50 mL of saline solu-
tion and 50 mL of 5% glucose solution deep in the subcuta-
neous tissue on a daily basis in order to prevent dehydration.
Empyema verification and pleural specimens
After 24 h applying bacteria 8 rabbits from the experi-
mental group were anesthetized again, and subjected to tho-
racocentesis. We evacuated 2 mL of pleural effusion from
each rabbit and divided this specimen into 4 parts: for micro-
biological, biochemical, immunological and hematological
analysis. We analyzed values of with blood cells (WBC),
LDH, glucose and pH of the effusion. Pleural fluid samples
were put into blood agar in order to observe bacterial colo-
nies growth. Empyema was considered where the effusion
specimen was apparently purulent, or if the glucose was <
2.3 mmol/L (normal range: 4.1–5.9 mmol/L), pH < 7.10 and
LDH > 1 000 U/L.  Both  lungs  of  all  experimental  animals
were histopathologically examined.
Glucose and LDH values were measured under the Ad-
via 1800 Chemistry System, (Siemens Germany), and WBC
under the Advia Hematology System (Siemens Germany)
device. Pleural fluid pH values were measured on a digital
pH meter (Model 4500, Beckman, USA). Thoracocentesis in
8 experimental rabbits was performed 24, 48, 72 and 96 h
after the bacteria administration.
Animals’ well-being and the end of experiment
The experiment lasted 7 days and in this period we re-
spected all the principles of animals’ well-being. All experi-
mental animals were sacrificed with a lethal intravenous dose
of pentobarbital injected through the ear vein, then we per-
formed autopsy and took lungs for histopathological exami-
nation.
Histopathological examination
The lungs from empyemic side of all experimental ani-
mals and the lung of one control animal were taken for
histopathological examination.
We used 4 tissue samples of each rabbit lung specimen,
parafinized them and hematoxylin eosin (HE) stained. We
randomized 5 HE slides of each tissue sample and did micro-
scopic measurement on 4 microscopic fields. In that way we
had done 20 measurements of pleural thickness of each tis-
sue sample.
Statistical analysis
The results were presented as mean values with stan-
dard deviation. The significant differences between more
than 2 groups were analyzed using one-way ANOVA test
(post-hoc Tukey test). The relationships among variables
were evaluated by Pearson's correlation analysis. A p value
of less than 0.05 was taken to be significant. The obtained
data were processed through the Star for Windows, R.4.5.
software package.
Results
In 4 rabbits the pleural specimens were scarce and clear
or there was no pleural effusion following the thoracocente-
sis 24 and 48 h after the bacteria administration. After the
autopsy we did not find any intrapleural changes other than
pleural congestion with a few mL of clear effusion and in-
tense smell of turpentine. These animals were excluded, and
there were 8 rabbits left in the experimental group.
The mean values ± SD of leukocyte count, LDH, glu-
cose and pH in the pleural fluid specimens obtained by tho-
racocentesis in 8 rabbits 24, 48, 72 and 96 h after the bacteria
administration are shown in Table 1. The dynamics of leuko-
cyte, glucose and pH values alterations in the function of
time are shown in Figures 1, 2 and 3.Strana 494 VOJNOSANITETSKI PREGLED Volumen 71, Broj 5
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Fig. 1 – The values (ʉ ± SD) of pleural fluid leukocytes count
vs time after intrapleural bacterial injection in 8 rabbits.
WBC – white blood cells.
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Fig. 2 – The values (ʉ ± SD) of pleural glucose vs time after
intrapleural bacterial injection in 8 rabbits.
6
6,2
6,4
6,6
6,8
7
7,2
7,4
7,6
7,8
24 48 72 96
Hours
p
H
Fig. 3 – The values (ʉ ± SD) of pleural effusion pH vs time af-
ter intrapleural bacterial injection in 8 rabbits.
The mean value of leukocytes found after 24 h was:
34.75 ± 6.13 u10
9/L, LDH 17,000 ± 4.69 U/L, glucose 1.23
± 0.45 mmol/L and pH 6.97 ±  0,15. These values entirely
met the Light's criteria for complex and complicated parap-
neumonic effusions and empyema, and 5 of 8 samples
showed bacterial growth on blood agar.
The mean value of leukocytes found in pleural fluid af-
ter 48 h was: 27.62 ± 4.62 u10
9/L, LDH 10.12 ± 4.51 U/L,
glucose 3.23 ± 0.44 mmol/L and pH 7.10 ± 0.09. High levels
of leukocytes and LDH were retained, and low values of glu-
cose and pH were the consequence of intense glucose me-
tabolism and a higher production of acid metabolic products
(Figures 2 and 3). Two of eight specimens showed bacterial
growth on the blood agar plate.
After 72 and 96 h the mean glucose and pH values were
4.15 ± 0.42 mmol/L, 4.83 ± 0.46 mmol/L and 7.22 ± 0.03,
7.28 ± 0.02, respectively, coming out from the empyema
limits. Leukocytes dropped to 15.62 ± 4.20 u10
9/L after 72 h,
and came into the normal range of 5.62 ± 2.87 u10
9/L 96 h
after the bacteria injection. There was no bacteria growth af-
ter 72 and 96 h.
We found a significant statistical difference for all the
values of leukocytes as well as glucose at any thoracocente-
sis time (p < 0.05). No significant statistical difference was
found between LDH values measured after 48 and 72 h as
well as 72 and 96 h after the bacteria injection. There was no
significant statistical difference for pH values in the pleural
samples after 24–48, 48–72 and 72–96 h from bacteria ad-
ministration.
We found a positive correlation between leukocytes
count and the LDH values (r = 0.071, p < 0.001) (Figure 4),
but a negative correlation between leukocytes count and the
glucose level (r = 0.864, p < 0.001) (Figure 5) and between
leukocytes count and the pH level in the pleural effusion (r =
0.894, p < 0.001) (Figure 6).
Table 1
Values of pleural fluid parameters for 8 rabbits over time induced by Staphylococcus aureus and
Escherichia coli application
Hours Parameters 24 48 72 96
WBC (u10
9/L), ʉ ± SD 34.75 ± 6.13 27.62 ± 4.62 15.62 ± 4.20 5.62 ± 2.87
LDH (U/L),  ʉ ± SD 17.00 ± 4.69 10.12 ± 4.51 6.50 ± 2.72 4.00 ± 1.92
Glucose  (mmol/L),  ʉ ±
SD 1.23 ± 0.45 3.23 ± 0.44 4.15 ± 0.42 4.83 ± 0.46
pH,  ʉ ± SD 6.97 ± 0.15 7.10 ± 0.09 7.22 ± 0.03 7.28 ± 0.02
WBC – white blood cells; LDH – lactate dehydrogenase.
0 5 10 15 20 25 30 35 40 45
WBC (109/L)
0
2
4
6
8
10
12
14
16
18
20
22
24
26
L
D
H
 
(
U
/
L
)
95% confidence
r = 0.8943  t = 10.94  p < 0.001
Fig. 4 – A positive correlation between leukocytes count and
lactate dehydrogenese (LDH) value in experimentally
induced pleural effusion in 8 rabbits.Volumen 71, Broj 5 VOJNOSANITETSKI PREGLED Strana 495
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Fig. 5 – A negative corelation between glucose level and
leukocytes count in experimentally induced pleural effusion
in 8 rabbits.
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Fig. 6 – A negative correlation between leucocytes count and
pH value in experimentally induced pleural effusion in 8
rabbits.
The animals from the experimental group and one rab-
bit from the control group were sacrificed on the  day 7 of
the autopsy. Five of 8 rabbits had purulent effusion, detritus
and fibrin layers in the pleural space (Figures 7 and 8). In 3
animals pleural adhesions were dominant with a few millili-
tres of turbid effusion (Figure 9).
Fig. 7 – Rabbit empyema lung covered with fibrin layers and
purulent detritus.
Fig. 8 – Empyemic space with fibrin and purulent detritus.
The control lung did not sustain any macroscopic change.
Fig. 9 – Experimentally induced purulent pleural infection
causes inflammatory infiltration in subvisceral part of the
lung parenchima at the point of the thickest fibropurulent
layer.
Microscopic examination of HE slides revealed thick-
ness of visceral pleura with prevalent granulocytes infiltrate,
fibroblasts and endotel cells proliferation along with purulent
detritus on the pleural surface (Figure 10).
Fig. 10 – Thickened visceral pleura because of submesothe-
lial inflammatory infiltration (HE stain, u5).Strana 496 VOJNOSANITETSKI PREGLED Volumen 71, Broj 5
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The mean value ± SD for visceral pleura thickness in
the experimental group (n = 8 rabbits) was 144.18 ± 24.64
ȝm. The mean value ± SD of fibroblast number in thickened
visceral pleura of the experimental group (n = 8 rabbits) was
196.27 ± 41.20. Macroscopic intrapleural and microscopic
lung findings of the control animal were quite normal and the
mean value of 20 measurements for visceral pleura thickness
was 38.54 ȝm and the mean value for fibroblast number was
11.30.
Discussion
Despite the extensive experience in the use of Büllau
underwater thoracic drainage and decortication, as well as
the introduction of new treatment methods such as fibrino-
lytic therapy video-assisted thoracoscopic surgery (VATS),
empyema patients still remain a serious medical problem and
therapeutic challenge 
17–19.
The American College of Chest Physicians published a
clinical practice guideline on the medical and surgical treat-
ment of parapneumonic effusions (PPE), and after compre-
hensive analysis they found only 3 relevant randomized con-
trolled studies 
20. Ten years after this meta analysis, the
situation in this field has not changed substantially 
11, 3.
It is well-known that 5–20% of hospitalized patients
with parapneumonic effusions progress to empyema, and no
thoracic surgery center has enough patients per year to per-
form a prospective study. In addition, it is very difficult to
make stratification of these patients because of significant
differences among them.
The most convincing examples of a different approach
to empyema treatment include the use of antibiotics only 
21,
or repeated thoracocentesis in the treatment of complicated
parapneumonic effusions and empyema 
3, 22, as well as appli-
ance of video-assisted thoracoscopic surgery in chronic em-
pyema treatment 
1, 11.
In the absence of quality research studies, recommen-
dations for pleural infection treatment depends on patho-
physiologic research, small studies and experts’ opinions 
23.
These circumstances were the reason for experimental
empyema model development, which would be able to offer
similar conditions found in human pleural infection. These
models have been used for almost a century to solve the
problems and controversies in empyema treatment.
Graham and Bell 
13 made the first experimental empy-
ema model in 1918 to investigate the causes of a very high
mortality rate (up to 60%) among American soldieries in the
World War I. They used dogs in their experiment and con-
cluded that the open pleural drainage, prematurely per-
formed, was the main cause of such a high mortality rate.
Then they formed the Empyema Commission which intro-
duced the closed tube underwater pleural drainage in empy-
ema treatment, and the mortality rate dropped down to 10%.
During their work investigators came to know that any
direct intrapleural application of bacteria without causing a
sterile exudative pleurisy before such application would end
with animal's death due to sepsis or with spontaneous healing
without signs of pleural infection  
24, 3.
In late 1970's, Sahn and Potts 
25 made the turpentine
rabbit experimental empyema model. Empyema was induced
with 10
9 K. pneumoniae injected in the pleural space. Sterile
pleurisy was provoked with 0.3 mL of turpentine 96 h before
the bacterial injection.
In this paper the authors estimated the influence of ad-
ministered turpentine on leucocytes number, pH, pO2 and
pCO2 values in pleural exudates in the first 96 h. They re-
vealed that in turpentine-provoked pleural effusions there
was no increase of leucocytes number and bacteria growth
which are responsible for metabolic activity. That was why
the values of estimated the parameters did not exceed the
normal range. It was very important to find that chemical
injury of mesothelial cells did not affect parameters which
we used for empyema classification. This model was used
for research of pharmacological characteristics and thera-
peutic efficacy of gentamicin 
15. Turpentine rabbit experi-
mental empyema model with 10
10/mL Escherichia coli was
applied for the research of clarithromycin efficacy, newer
quinolones and azithromycin penetration in the empyema
fluid 
9, 26, 27. This model was also used to study linezolid and
ertapenem pharmacokinetics in parapneumonic effusions 
28.
This model has been proved as a better one compared with
our model with two bacteria. What is next? We will try to
create experimental empyema model with 10
10/mL Escher-
ichia coli, because there is 10 times more bacteria than we
accepted as optimal concentration.
The pig experimental empyema model had used an um-
bilical cord instead of the turpentine in order to provoke sterile
effusion. Mavreudis et al. 
29 applied this model to prove that
the possibility for empyema induction depends on the number
and strain of administered bacteria. In the case of application
of B. fragilis bacteria, no animal developed empyema, but in
combination with S. aureus or E. coli, one third of animals de-
veloped empyema. One million bacteria caused empyema in
half of all animals, but with a hundred million bacteria, all
animals suffered from empyema. considering these results, we
decided to take 9 times more bacteria in a single (2 mL) intra-
pleural inoculums (4.5 u 10
8/mL) S. aureus 
9.
A similar research was conducted with the rabbit tur-
pentine empyema model 
30. The authors have studied how
particular bacteria influence the severity and evolution of
empyema. They found that the same number (10
8)
 of admin-
istered bacteria H. influenze, S. aureus and B. fragilis caused
empyema in one third, one half and two thirds of animals, re-
spectively.
 A combination with two bacteria was more suc-
cessful in empyema induction and 11 of 12 animals evolved
empyema.
Taking experience from our previous experiment when
we used only S. aureus in intrapleural injection and gained
more than one third of negative results, we decided to make a
new experimental empyema model using two bacteria: S.
aureus and E. coli. With the intention to make a greater
chance for empyema induction we applied again 9 times
more bacteria (1.5 Mc Farland/ml bacterial concentration)
than it was recommended for this bacterial combination. De-
spite this fact we succeeded to induce empyema only in 8 of
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Sasse et al. 
24 published their negative experiences in em-
pyema induction by application of a monoculture bacterial
specimen upon previously applied different cofactors such as
mineral oil, E. coli supernatant, nutrition agar and talc. These
authors published that pH value in their turpentine model effu-
sion was under 7.1 only within the first 6 h, and after 24 h it
rose to 7.25. The glucose level was 45 mg/dL only in the first
24 h and after that exceeded 100 mg/dL.
We got better results using the turpentine model with
two bacteria compared with the above-mentioned data. In
our experimental model the pH value 48 h after bacteria ad-
ministration was 7.10, and 7.22 after 72 h. The glucose level
was 1.23 mmol/L 24 h after we administered bacteria in
pleural space, and 3.23 mmol/L after 48 hours. Glucose
value returned in the normal range (4.1–5.9 mmol/L) 72 h
after bacteria administration and was 4.15 mmol/L.
A positive correlation found between a growing number
of leukocytes and LDH values could be explained with in-
tense cellular destruction in an acute inflammation.
Also, with the growth of leukocytes count a glucose
level became lower, which was in concordance with the re-
sults of other authors 
4. This might be explained with phago-
cytosis and intense bacterial metabolism which was followed
by a growing intensity of glycolysis. In those conditions a
bigger production of acid metabolic products was present so
the measured values of pleural fluid pH were the lowest on
the first day, when the intensity of inflammation was obvi-
ously the highest, and after that they became gradually big-
ger.
Other authors 
4 using the turpentine model with Strepto-
coccus pneumoniae determined the level of glucose, the value
of LDH and the number of leucocytes in pleural effusion sam-
ples. The values of glucose they found were under 1.4 mmol/L
at 72 h after bacteria administration, whereas the highest num-
ber of leucocytes was 5.95 u 10
9/L. The numbers of leucocytes
that we found in effusion samples were 35 u 10
9/L at 24 h and
5.62 u 10
9/L at 72 h after administered bacterial inoculums.
In their latest rabbit experimental empyema model
Sasse et al. 
24 used nutritive brain heart infusion (BHI) agar
aimed at keeping bacteria inside the pleural space without
prior causing of chemical pleurisy. In this experiment they
administered 10
8 Pasteurella multocida, a very virulent rab-
bit pathogen. Using this model the authors studied thoraco-
centesis effectiveness and its possibility to replace thoracic
drainage in the empyema treatment, and the importance of
timing for thoracic drainage to improve drainage effi-
cacy 
3, 14. This model was also used for studying antibiotics’
effectiveness by measuring their concentration in the pleural
space after the parenteral administration was con-
ducted 
9, 15, 31. On this model Sasse et al. 
24 studied the role of
TGF-  ȕ in the process of pleural fibrosis. These authors
documented that the level of TGF-ȕ1 correlates with micro-
scopic thickness and the number of fibroblast in visceral
pleura. This research suggests that TGF-ȕ1 inhibition can re-
duce the intensity of residual pleural fibrosis.
In this empyema model the authors pH values lower
than 7.1 in the samples collected 24, 48, 72 and 96 h after
bacteria administration. Glucose level obtained in the effu-
sion sample 48 h after bacteria injection was 43 mg/dL, a lit-
tle above the empyema level (40 mg/dL). After 72 h, glucose
values came into normal range. The glucose values obtained
in this experimental empyema model were very similar to
those we got in our empyema model.
After they sacrificed experimental animals, they found
a dense purulent content, as well as fibrin adhesions within
all pleural spaces of experimental rabbits. The rabbits from
the control group did not have any intrapleural pathological
changes.
We found purulent exudates and fibrin adhesions in 5 of
8 rabbits. Three rabbits had as dominant fibrin adhesions
with a very little turbid pleural effusion. Two control rabbits
also had no intrapleural pathological findings.
In this experimental model modification the authors
placed a chest tube in the pleural space and then fixed it in
the subcutaneous tissue of the scapular region, using the
drain for the substances application and taking pleural fluid
samples. Using this model of experimental empyema Zhu et
al. 
19 compared efficacy of the separate and common use of
recombined human deoxyribonuclease and tissue plazmino-
gen activator in the treatment of fibropurulent stage of em-
pyema. We did not fix the drain in the subcutaneous tissue
due to possible formation of fibrin septa that could block the
discharge of pleural fluid samples.
Moxifloxacin efficiency research can serve as evi-
dence of the turpentine model reliability. Twenty six rab-
bits were used for turpentine empyema model with Strepto-
coccus pneumoniae and another 26 rabbits for empyema
model with Pasteurella multocida in nutritive agar. In the
results analysis after moxifloxacin administration they did
not make differences between these 2 models of experi-
mental empyema 
31.
Despite many attempts to provoke experimental empy-
ema by using P. multocida we did not succeed because the
rabbits were dying even after inoculation of l0
5 bacteria.
Bacteria application in solution of BHI agar did not result in
the desired effect of keeping bacteria in the pleural space as
all animals died with the signs of sepsis.
What is next? Rabbit experimental empyema model
with P. multocida in BHI agar is one of the most efficient
models and we will try to establish it again, now with new
standardised bacterial cultures.
In the last 10 years empyema research has become basic
again. Studying the role of cytokines, the powerful mediators
of inflammation and tissue reparation, lowered these re-
searches to the cellular and molecular levels.
Researches have not continued with the expected inten-
sity and the present situation leaves enough room to continue
this work the accomplishments of which would be imple-
mented in practice in the area of the empyema treatment.
The fact that without these reliable experimental empy-
ema models these researches would not be feasible accentu-
ates their necessity and importance. In particular, we have
been interested for the influence of some cytokines on the
development of pleural fibrosis and possibilities of their in-
hibition. For these researches we created not so efficient rab-
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We plan to investigate the influence of TGF-ȕ on in-
flammatory-proliferative processes and angiogenesis and
complex cytokines network in the purulent pleural infection.
Because of that we made our own model with two bacteria.
Unfortunately we are not entirely satisfied with the results.
What are the next steps? The third answer to this ques-
tion would be creation of the rat experimental empyema
model.
Conclusion
With the intention to obtain a reliable empyemic model
with more intensive pleural reaction we created the model with
two different human pathogen bacteria and used 9 times higher
number of bacteria than recommended in published papers.
The combination of two human pathogens (E. coli and S.
aurous) has already been proven as very effective in experi-
mental emphysema causing. We generated acceptable, but not
satisfactory results. They were a little better than in our ex-
periment with monobacterial empyema, but not as good as we
expected and came across in published respectable articles.
We did not succeed in provoking an empyema in 40% of ex-
perimental animals. Obviously, the number of bacteria and
bacterial combination of human pathogens are not sufficiently
reliable. We plan to continue our research concerning cytoki-
nes network and angiogenesis in pleural inflammation and we
need a better and more reliable experimental empyema model.
Our previous experiences justify new decision making.
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